Topics
Cardiovascular diseases
Defibrillator access across Australia: the first step in avoiding a chain of fatality
To survive a sudden cardiac arrest, you need to be in the “right place at the right time”; but should someone’s chance of surviving a sudden cardiac arrest really come down to a roll of the dice?
Elizabeth Paratz · Gregory J Page · Garry LR Jennings
Seven vessel spontaneous coronary artery dissection and concurrent transient global amnesia after an emotional trigger
A 60-year-old woman presented to the emergency department with confusion and memory loss on the day of her father’s death
Nikolaos Papadopoulos · Ashleigh Dind · Karam Alzuhairi · Peter Caspari
Cardiovascular risk management in the peri‐operative setting
Accurate peri-operative risk assessment is important to enable shared decision making and to optimise the multidisciplinary management of patients undergoing major non-cardiac surgery
Shehane Mahendran · Aravinda Thiagalingam · Graham Hillis · Richard Halliwell · Henry CC Pleass · Clara K Chow
Myocarditis in Australian children following SARS‐CoV‐2 infection or COVID‐19 vaccination: a retrospective case series
Awareness that the myocarditis risk in children with SARS-CoV-2 infections differs from that for adults should inform vaccination strategies
Patrick Walker · Timothy C Lai · Silja Schrader · Nigel Crawford · Daryl R Cheng
Hypertensive retinopathy in the paediatric setting
A 12-year-old girl presented to a general practitioner with a two-day history of progressively worsening blurry vision
Nandini Singh · Kanika Chaudhri · Caroline Catt
Cardiovascular risk management following gestational diabetes and hypertensive disorders of pregnancy: a narrative review
Pregnancy can be seen as a stress test for cardiometabolic conditions, where the physiological demands of pregnancy can unmask women at risk for CVD
Simone Marschner · Anushriya Pant · Amanda Henry · Louise J Maple‐Brown · Lisa Moran · N Wah Cheung · Clara K Chow · Sarah Zaman
Coronary calcium scoring for guiding lipid‐lowering therapy is cost‐effective: time to remove barriers to its use
Widespread, inexpensive CAC scanning could economically expand access to statin therapy to those at highest risk
Erfan Tasdighi · Michael J Blaha
The cost‐effectiveness of coronary calcium score‐guided statin therapy initiation for Australians with family histories of premature coronary artery disease
Expanding eligibility for statin therapy should selectively target people with subclinical atherosclerosis rather than simply lowering treatment thresholds
Prasanna Venkataraman · Amanda L Neil · Geoffrey K Mitchell · Tony Stanton · Stephen Nicholls · Andrew M Tonkin · Gerald F Watts · Thomas H Marwick
Historic breakthrough for public access defibrillation in Australia
To the Editor: Over 26000 Australians experience out‐of‐hospital cardiac arrest (OHCA) each year, with almost nine in ten of these patients not surviving to hospital discharge or 30 days.1 Although it is known that swift defibrillation increases the possibility of patient survival in these situations, and that initial defibrillation by first responders (regardless of training) is associated with greater survival than initial defibrillation by emergency medical services,2 in Australia, less than 2% of OHCA cases receive defibrillation by a bystander.1 It is likely that this is driven by the limits to publicly accessible automated external defibrillators (AEDs) in Australian communities.3 On 30 November 2022, South Australia took a major step to deal with this problem and reduce death from OHCA. The SA Parliament passed the Automated External Defibrillators (Public Access) Bill 2022,4 making SA the first state or territory in Australia, and one of few in the world, to mandate the public provision of AEDs. The legislation, introduced by Member of the Legislative Council, the Hon Frank Pangallo of the SA‐BEST party, had bipartisan political support and backing from various organisations, and follows a recent public health campaign to install AEDs in Adelaide. The Bill will come into effect for government and public buildings in 2025 and a variety of private buildings in 2026, with awareness campaigns, grant programs, and communication with organisations being the focus of the interim period. The expected cost to the SA government of $7.2 million across four years is weighed against the $2 billion gross domestic product loss that Australia incurs annually as a result of sudden cardiac arrest.5 The health and economic benefits of public access defibrillation to Australian society are large. For the benefit of all Australians, other states and territories should follow the example set by SA and move to implement similar laws mandating the public availability of AEDs in their communities.
Joshua G Kovoor · Gregory J Page · Pramesh Kovoor
Cardiovascular disease risk screening in Australia: evidence and data gaps
Data on the expected effectiveness of a formal cardiovascular risk screening are needed
Ellie Paige · Natalie Raffoul · Emma Lonsdale · Emily Banks
Emergency department presentations during the COVID‐19 pandemic in Queensland (to June 2021): interrupted time series analysis
Restrictions should be accompanied by advice about appropriate locations for seeking medical care, by condition severity and type
Amy L Sweeny · Gerben Keijzers · Andrea Marshall · Emma J Hall · Jamie Ranse · Ping Zhang · Gary Grant · Ya‐Ling Huang · Dinesh Palipana · Yang D Teng · Benjamin Gerhardy · Jaimi H Greenslade · Philip Jones · Julia L Crilly
Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self‐Screening, Management And guideline‐Recommended Therapy (AF Self‐SMART) study
AF self-screening in general practice waiting rooms is feasible, and could reduce the number of AF-related strokes
Katrina Giskes · Nicole Lowres · Jessica Orchard · JiaLin Li · Kirsty McKenzie · Charlotte Mary Hespe · Ben Freedman
Native valve infective endocarditis: a rare complication of rat bite fever caused by Streptobacillus moniliformis
A 44-year-old man presented to the emergency department with left knee monoarthritis
Caitlin Paul · Joseph O'Brien · Sarah Huffam · Daryl Ridley
The long term implications of fertility therapy for the health of women
Cardiovascular disease mortality is not increased in women undergoing IVF, but vigilant surveillance is nonetheless required
Robert J Norman
Long term all‐cause and cardiovascular disease mortality among women who undergo fertility treatment
Reassuringly, fertility treatment does not increase long term all-cause or CVD mortality risk
Stephanie R Yiallourou · Dianna Magliano · Tilahun N Haregu · Melinda J Carrington · Daniel L Rolnik · Luk Rombauts · Andre Rodrigues · Jocasta Ball · Fiona J Bruinsma · Fabricio Da Silva Costa
Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria
A 58-year-old man presented with 4–6 weeks of lower limb muscle weakness, an elevated serum creatine kinase level of 344 U/L, painful paraesthesia, and weight loss
Laura Bywater · Anthea C Gist · Rahul G Muthalaly · Joanna Loh · Ian Simpson · Anthony J White · Andy KH Lim
Ambulance ramping and patients with cardiac‐type symptoms: understanding the unloading queue
Prioritisation for unloading, once obvious cardiac emergencies have been excluded, disadvantages women and older people
Gao Jing Ong · John D Horowitz
Differences in the pre‐hospital management of women and men with stroke by emergency medical services in New South Wales
Refining the assessment of symptoms in women in pre-hospital emergency services care could improve patient outcomes
Xia Wang · Cheryl Carcel · Benjumin Hsu · Sultana Shajahan · Matthew Miller · Sanne Peters · Deborah A Randall · Alys Havard · Julie Redfern · Craig S Anderson · Louisa Jorm · Mark Woodward
Consensus statement on the current pharmacological prevention and management of heart failure
New recommendations for the pharmacological management of heart failure
Andrew P Sindone · Carmine De Pasquale · John Amerena · Christine Burdeniuk · Alicia Chan · Andrew Coats · David L Hare · Peter Macdonald · Aaron Sverdlov · John J Atherton
Sodium–glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?
SGLT2 inhibitors show promise in improving metabolic and cardiovascular health in type 1 diabetes, yet ideal candidates for therapy require careful selection
Jennifer R Snaith · Jerry R Greenfield
The influence of ambulance offload time on 30‐day risks of death and re‐presentation for patients with chest pain
Longer ambulance offload times are associated with greater 30-day risks of death and ambulance re-attendance
Luke P Dawson · Emily Andrew · Michael Stephenson · Ziad Nehme · Jason Bloom · Shelley Cox · David Anderson · Jeffrey Lefkovits · Andrew J Taylor · David Kaye · Karen Smith · Dion Stub
Low risk chest pain? Make the negative a positive
Emergency department presentations are opportunities to discuss cardiovascular risk factors while the patient’s awareness of their importance is heightened
Christopher Zeitz · Angus Baumann
Ulcerative colitis and acute perimyocarditis
A 32-year-old man with 15 years of intermittent bloody diarrhoea was diagnosed with ulcerative proctosigmoiditis
Kenneth K Cho · Yanna Ko · Kelly Nilsen · Christine Verdon · Giuseppe Femia
Value of single troponin values in the emergency department for excluding acute myocardial infarction in Aboriginal and Torres Strait Islander people
Aboriginal and Torres Strait Islander people may benefit from culturally appropriate cardiac risk factor management
Jaimi H Greenslade · Sara Berndt · Laura Stephensen · Katrina Starmer · Greg Starmer · William Parsonage · Victor Lau · Tileah Drahm‐Butler · Tania Davis · Virginia Campbell · Richard Stone · Robert Bonnin · Sarah Ashover · Tanya Milburn · Elizabeth Mowatt · Karlie Proctor · Anthony Brazzale · Louise Ann Cullen
Poor achievement of lipid targets after acute coronary syndrome: what can we improve?
Overcoming problems that impede the delivery of evidence-based care is needed to bridge gaps between science and improving health
Sher May Ng · Jiliu Pan · Ajay K Gupta